Search Results For :: women
-
mHealth Solutions Market by Apps (Women Health, Diabetes, Mental Health), Connected Devices (Glucose & Blood Pressure Monitor, Peak Flow Meter), Services (Remote Monitoring, Consultation), End User (Providers, Patients, Payers) & Region - Global Forecasts to 2028
The global mHealth solutions market in terms of revenue was estimated to be worth $119.5 billion in 2023 and is poised to reach $395.0 billion by 2028, growing at a CAGR of 27.0% from 2023 to 2028. Koninklijke Philips N.V. (Netherlands), Medtronic plc (Ireland), Johnson & Johnson (US), OMRON Healthcare Co., Ltd. (Japan), Cerner Corporation (US), Apple, Inc. (US), AliveCor, Inc. (US), AirStrip Technologies (US), athenahealth, Inc. (US), iHealth Lab Inc. (US), AT&T Inc. (US), AgaMatrix, Inc. (US), Cisco Systems, Inc. (US), Fitbit Inc. (US), OSP Labs (US), SoftServe (US), Garmin, Ltd. (US), Dexcom, Inc. (US), Tunstall Healthcare (UK), Teladoc Health, Inc. (US), ZTE Corporation (China), and My mHealth Limited (UK) are the major players in this market. These companies are majorly focusing on the strategies such as acquisitions, product launches, agreements, collaborations, partnerships, and expansions in order to remain competitive and further increase their share in the market.
- Published: March 2023
- Price: $ 4950
- TOC Available:
-
Vitamin D Market by Analog (Vitamin D2, Vitamin D3), Form (Dry, Liquid), Application (Feed & Pet Food, Pharma, Functional Food, and Personal Care), End Users (Adults, Pregnant Women, and Children), IU Strength and Region - Global Forecast to 2027
According to MarketsandMarkets, the global vitamin D market is projected to reach USD 1.9 billion by 2027, recording a CAGR of 7.1% during the forecast period. This report includes a study on the marketing and development strategies, along with the product portfolios of leading companies. It consists of profiles of leading companies, such as Zhejiang Garden Biochemical High-Tech Co.Ltd (China), Koninklijke DSM N.V. (Netherlands), Zhejiang Xinhecheng Co., Ltd. (China), Taizhou Haisheng Pharmaceutical Co., Ltd. (China), Xiamen Jindawei Vitamin Co., Ltd. (China), Fermenta Biotech Ltd. (India), Zhejiang Medicine Co., Ltd.(China), BASF (Germany), and Dishman Group (India).
- Published: November 2022
- Price: $ 4950
- TOC Available:
-
Specialty PACS Market by Type (Radiology, Orthopedics, Oncology, Pathology, Endoscopy, Women's Health), Deployment Model (On premise, Cloud), Component (Software, Service), End User (Hospital, Clinic, Diagnostic Centers, Research) - Global Forecasts to 2024
The global specialty PACS market size is projected to reach USD 3.5 billion in 2024, at a CAGR of 6.0%. Some of the prominent players offering in this market includes IBM Corporation (Merge Healthcare Incorporated) (US), McKesson Corporation (US), Agfa Healthcare (Belgium), Carestream Health (a part of Onex Corporation) (Canada), Philips Healthcare (Netherlands), Sectra AB (Sweden), Siemens Healthineers (Germany), Novarad (US), INFINITT North America (US), Intelerad Medical Systems (Canada), Topcon Corporation (Japan), Sonomed Escalon (US), Canon USA, Inc. (US) (a subsidiary of Canon Inc.), Visbion (UK), and EyePACS, LLC (US).
- Published: September 2019
- Price: $ 4950
- TOC Available:
-
Dietary Supplements Market, By Type (Botanicals, Vitamins, Minerals, Amino acids, Enzymes, Others), By Category (Infant Dietary Supplements, Children Dietary Supplements, Adult Dietary Supplements, Pregnant women Dietary Supplements, Old-Aged Dietary Supplements), By Dosage Format (Capsules, Tablets, Powder, Liquids, Soft Gels, Gel Caps)
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Dietary Supplements Market, By Type (Botanicals, Vitamins, Minerals, Amino acids, Enzymes, Others), By Category ( Infant Dietary Supplements, Children Dietary Supplements, Adult Dietary Supplements, Pregnant women Dietary Supplements, Old-Aged Dietary Supplements), By Dosage Format (Capsules, Tablets, Powder, Liquids, Soft Gels, Gel Caps)
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
mHealth Solutions Market by Apps (Women Health, Diabetes, Mental Health), Connected Devices (Glucose & Blood Pressure Monitor, Peak Flow Meter), Services (Remote Monitoring, Consultation), End User (Providers, Patients, Payers) & Region - Global Forecasts to 2028
The global mHealth solutions market in terms of revenue was estimated to be worth $119.5 billion in 2023 and is poised to reach $395.0 billion by 2028, growing at a CAGR of 27.0% from 2023 to 2028. Koninklijke Philips N.V. (Netherlands), Medtronic plc (Ireland), Johnson & Johnson (US), OMRON Healthcare Co., Ltd. (Japan), Cerner Corporation (US), Apple, Inc. (US), AliveCor, Inc. (US), AirStrip Technologies (US), athenahealth, Inc. (US), iHealth Lab Inc. (US), AT&T Inc. (US), AgaMatrix, Inc. (US), Cisco Systems, Inc. (US), Fitbit Inc. (US), OSP Labs (US), SoftServe (US), Garmin, Ltd. (US), Dexcom, Inc. (US), Tunstall Healthcare (UK), Teladoc Health, Inc. (US), ZTE Corporation (China), and My mHealth Limited (UK) are the major players in this market. These companies are majorly focusing on the strategies such as acquisitions, product launches, agreements, collaborations, partnerships, and expansions in order to remain competitive and further increase their share in the market.
- Published: March 2023
- Price: $ 4950
- TOC Available:
-
Vitamin D Market by Analog (Vitamin D2, Vitamin D3), Form (Dry, Liquid), Application (Feed & Pet Food, Pharma, Functional Food, and Personal Care), End Users (Adults, Pregnant Women, and Children), IU Strength and Region - Global Forecast to 2027
According to MarketsandMarkets, the global vitamin D market is projected to reach USD 1.9 billion by 2027, recording a CAGR of 7.1% during the forecast period. This report includes a study on the marketing and development strategies, along with the product portfolios of leading companies. It consists of profiles of leading companies, such as Zhejiang Garden Biochemical High-Tech Co.Ltd (China), Koninklijke DSM N.V. (Netherlands), Zhejiang Xinhecheng Co., Ltd. (China), Taizhou Haisheng Pharmaceutical Co., Ltd. (China), Xiamen Jindawei Vitamin Co., Ltd. (China), Fermenta Biotech Ltd. (India), Zhejiang Medicine Co., Ltd.(China), BASF (Germany), and Dishman Group (India).
- Published: November 2022
- Price: $ 4950
- TOC Available:
-
Women's Healthcare Market by Drugs (Prolia, Xgeva, Evista, Mirena, Zometa, Reclast, Nuvaring, Primarin, Actonel), Application (Female Infertility, Postmenopausal Osteoporosis, Endometriosis, Contraception, PCOS, Menopause) & Region - Global Forecast to 2024
The global women's healthcare market growth is primed to transition from $9.6 billion in 2019 to $17.8 billion by 2024, showcasing a strong CAGR of 13.2%. Key drivers of this growth include increasing chronic health conditions among women, government initiatives for population control, and rising demand for contraceptives.
- Published: January 2020
- Price: $ 4950
- TOC Available:
-
Specialty PACS Market by Type (Radiology, Orthopedics, Oncology, Pathology, Endoscopy, Women's Health), Deployment Model (On premise, Cloud), Component (Software, Service), End User (Hospital, Clinic, Diagnostic Centers, Research) - Global Forecasts to 2024
The global specialty PACS market size is projected to reach USD 3.5 billion in 2024, at a CAGR of 6.0%. Some of the prominent players offering in this market includes IBM Corporation (Merge Healthcare Incorporated) (US), McKesson Corporation (US), Agfa Healthcare (Belgium), Carestream Health (a part of Onex Corporation) (Canada), Philips Healthcare (Netherlands), Sectra AB (Sweden), Siemens Healthineers (Germany), Novarad (US), INFINITT North America (US), Intelerad Medical Systems (Canada), Topcon Corporation (Japan), Sonomed Escalon (US), Canon USA, Inc. (US) (a subsidiary of Canon Inc.), Visbion (UK), and EyePACS, LLC (US).
- Published: September 2019
- Price: $ 4950
- TOC Available:
-
In Vitro Fertilization Market by Product (Equipment, Reagent, Accessories), Equipment (Imaging, Incubator, Microscope, Micromanipulator), Procedure (Conventional, ICSI, donor), Cycle (Fresh, Frozen), End-user (Hospital, Clinic) - Global Forecast to 2029
The global in vitro fertilization market, valued at US$857M in 2023, is forecasted to grow at a 11.7% CAGR, reaching US$949M by 2024 and US$1,650M by 2029. Key drivers include rising infertility rates, advanced median age of women in childbearing years, increased funding and research activities, and improved techniques in IVF treatments globally.
- Published: August 2024
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 32
